Sfoglia per Autore
Epigenetic drugs as pleiotropic agents in cancer treatment: Biomolecular aspects and clinical applications
2007 Sigalotti, L; Fratta, E; Coral, S; Cortini, E; Covre, A; Nicolay, H; Anzalone, L; Pezzani, L; Di Giacomo, Am; Fonsatti, E; Colizzi, F; Altomonte, M; Calabro', L; Maio, M
Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases
2009 Di Giacomo, Am; Danielli, R; Guidoboni, M; Calabro', L; Carlucci, D; Miracco, C; Volterrani, L; Mazzei, Ma; Biagioli, M; Altomonte, M; Maio, M
Weekly docetaxel vs. docetaxel-based combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer patients. The DISTAL-2 randomized trial
file con accesso da definire2009 Gebbia, V; Gridelli, C; Verusio, C; Frontini, L; Aitini, E; Daniele, B; Gamucci, T; Mancuso, G; Di Maio, M; Gallo, C; Perrone, F; Morabito, A; Calabro', L; And, Coauthors
High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients
2009 Logozzi, M; De Milito, A; Lugini, L; Borghi, M; Calabro', L; Spada, M; Perdicchio, M; Marino, Ml; Federici, C; Iessi, E; Brambilla, D; Venturi, G; Lozupone, F; Santinami, M; Huber, V; Maio, M; Rivoltini, L; Fais, S
Clinical studies with anti-CTLA-4 antibodies in non-melanoma indications
2010 Calabro', L; Danielli, R; Sigalotti, L; Maio, M.
CD40 expression by human melanocytic lesions and melanoma cell lines and direct CD40 targeting with the therapeutic anti-CD40 antibody CP-870.893
2010 Kabasi, A; Fonsatti, E; Natali, Pg; Altomonte, M; Bertocci, E; Cutaia, O; Calabro', L; Chiou, M; Tap, W; Chmielowski, B; Maio, M; Ribas, A
Epigenetically regulated clonal heretability of CTA expression profiles in human melanoma
2010 Fratta, E; Sigalotti, L; Colizzi, F; Covre, F; Nicolay, Hj; Danielli, R; Fonsatti, E; Altomonte, M; Calabro', L; Coral, S; Maio, M
Seventh annual meeting of the Italian Network for Tumor Biotherapy (NIBIT)
2010 Maio, M; Nicolay, Hj; Ascierto, Pa; Belardelli, F; Camerini, R; Colombo, Mp; Queirolo, P; Ridolfi, R; Russo, V; Fonsatti, E; Parmiani, G; Calabro', L; Nibit, Collaborators
Ipilimumab experience in heavily pre-treated patients with melanoma in an expanded access program at the University Hospital of Siena (Italy)
2011 Di Giacomo, Am; Danielli, R; Calabro', L; Bertocci, E; Nannicini, C; Giannarelli, D; Balestrazzi, A; Vigni, F; Riversi, V; Miracco, ; Biagioli, M; Altomonte, M; Maio, M
Expression and regulation of the B7-H3 receptor in human mesothelial and mesothelioma cells: a novel target for immunotherapeutic applications
file con accesso da definire2011 Calabro', L; Sigalotti, L; Fonsatti, E; Bertocci, E; Di Giacomo, Am; Danielli, R; Cutaia, O; Colizzi, F; Covre, A; Mutti, L; Natali, Pg; Maio, M.
Eighth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, October 7-9, 2010
2011 Maio, M; Nicolay, Hj; Ascierto, Pa; Belardelli, F; Camerini, R; Colombo, Mp; Queirolo, P; Ridolfi, R; Russo, V; Fonsatti, E; Nibit, ; Parmiani, G; Calabro', L
Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy
2012 Danielli, R; Ridolfi, R; Chiarion-Sileni, V; Queirolo, P; Testori, A; Plummer, R; Boitano, M; Calabro', L; Rossi, Cd; Giacomo, Am; Ferrucci, Pf; Ridolfi, L; Altomonte, M; Miracco, C; Balestrazzi, A; Maio, M.
First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial
2012 Gridelli, Cesare; Ciardiello, Fortunato; Gallo, Ciro; Feld, Ronald; Butts, Charles; Gebbia, Vittorio; Maione, Paolo; Morgillo, Floriana; Genestreti, Giovenzio; Favaretto, Adolfo; Leighl, Natasha; Wierzbicki, Rafal; Cinieri, Saverio; Alam, Yasmin; Siena, Salvatore; Tortora, Giampaolo; Felletti, Raffaella; Riccardi, Ferdinando; Mancuso, Gianfranco; Rossi, Antonio; Cantile, Flavia; Tsao, Ming-Sound; Saieg, Mauro; da Cunha Santos, Gilda; Carmela Piccirillo, Maria; Di Maio, Massimo; Morabito, Alessandro; Perrone, Francesco; Investigators, Torch; Calabro', Luana
Thymosin α1 in melanoma from the clinical trial setting to the daily practice and beyond
2012 Danielli, R; Fonsatti, E; Calabro', L; Giacomo, Am; Maio, M
Quality of Life Analysis of TORCH, a Randomized Trial Testing First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Chemotherapy in Advanced Non-Small-Cell Lung Cancer
2012 Di Maio, M; Leighl, Nb; Gallo, C; Feld, R; Ciardiello, F; Butts, C; Maione, P; Gebbia, V; Morgillo, F; Wierzbicki, R; Favaretto, A; Alam, Y; Cinieri, S; Siena, S; Bianco, R; Riccardi, F; Spatafora, M; Ravaioli, A; Felletti, R; Fregoni, V; Genestreti, G; Rossi, A; Fregoni, V; Genestreti, G; Rossi, A; Mancuso, G; Fasano, M; Morabito, A; Tsao, Ms; Signoriello, S; Perrone, F; Gridelli, C; Torch, Investigators; Calabro', L
Tenth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), SIENA, Italy, November 5-7, 2012
file con accesso da definire2013 Calabro', Luana
Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme
2013 Altomonte, M; Di Giacomo, A; Queirolo, P; Ascierto, P; Spagnolo, F; Bajetta, E; Calabro', L; Danielli, R; de Rosa, F; Maur, M; Chiarion-Sileni, V; Ferrucci, P; Giannarelli, D; Testori, A; Ridolfi, R; Maio, M.
Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme
2013 Di Giacomo, Am; Calabro', L; Danielli, R; Fonsatti, E; Bertocci, E; Pesce, I; Fazio, C; Cutaia, O; Giannarelli, D; Miracco, C; Biagioli, M; Altomonte, M; Maio, M
Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012
2013 Ascierto, Pa; Grimaldi, Am; Acquavella, N; Borgognoni, L; Calabro', L; Cascinelli, N; Cesano, A; Del Vecchio, M; Eggermont, Am; Faries, M; Ferrone, S; Fox, Ba; Gajewski, Tf; Galon, J; Gnjatic, S; Gogas, H; Kashani-Sabet, M; Kaufman, Hl; Larkin, J; Lo, Rs; Mantovani, A; Margolin, K; Melief, C; Mcarthur, G; Palmieri, G; Puzanov, I; Ribas, A; Seliger, B; Sosman, J; Suenaert, P; Tarhini, Aa; Trinchieri, G; Vidal-Vanaclocha, F; Wang, E; Ciliberto, G; Mozzillo, N; Marincola, Fm; Thurin, M.
Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial
2013 Calabro', Luana; Aldo, Morra; Ester, Fonsatti; Ornella, Cutaia; Giovanni, Amato; Diana, Giannarelli; Anna Maria Di Giacomo, ; Riccardo, Danielli; Maresa, Altomonte; Luciano, Mutti; Michele, Maio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Epigenetic drugs as pleiotropic agents in cancer treatment: Biomolecular aspects and clinical applications | 2007 | Sigalotti, L; Fratta, E; Coral, S; Cortini, E; Covre, A; Nicolay, H; Anzalone, L; Pezzani, L; Di ...Giacomo, Am; Fonsatti, E; Colizzi, F; Altomonte, M; Calabro', L; Maio, M | |
| Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases | 2009 | Di Giacomo, Am; Danielli, R; Guidoboni, M; Calabro', L; Carlucci, D; Miracco, C; Volterrani, L; M...azzei, Ma; Biagioli, M; Altomonte, M; Maio, M | |
| Weekly docetaxel vs. docetaxel-based combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer patients. The DISTAL-2 randomized trial | 2009 | Gebbia, V; Gridelli, C; Verusio, C; Frontini, L; Aitini, E; Daniele, B; Gamucci, T; Mancuso, G; D...i Maio, M; Gallo, C; Perrone, F; Morabito, A; Calabro', L; And, Coauthors | file con accesso da definire |
| High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients | 2009 | Logozzi, M; De Milito, A; Lugini, L; Borghi, M; Calabro', L; Spada, M; Perdicchio, M; Marino, Ml;... Federici, C; Iessi, E; Brambilla, D; Venturi, G; Lozupone, F; Santinami, M; Huber, V; Maio, M; Rivoltini, L; Fais, S | |
| Clinical studies with anti-CTLA-4 antibodies in non-melanoma indications | 2010 | Calabro', L; Danielli, R; Sigalotti, L; Maio, M. | |
| CD40 expression by human melanocytic lesions and melanoma cell lines and direct CD40 targeting with the therapeutic anti-CD40 antibody CP-870.893 | 2010 | Kabasi, A; Fonsatti, E; Natali, Pg; Altomonte, M; Bertocci, E; Cutaia, O; Calabro', L; Chiou, M; ...Tap, W; Chmielowski, B; Maio, M; Ribas, A | |
| Epigenetically regulated clonal heretability of CTA expression profiles in human melanoma | 2010 | Fratta, E; Sigalotti, L; Colizzi, F; Covre, F; Nicolay, Hj; Danielli, R; Fonsatti, E; Altomonte, ...M; Calabro', L; Coral, S; Maio, M | |
| Seventh annual meeting of the Italian Network for Tumor Biotherapy (NIBIT) | 2010 | Maio, M; Nicolay, Hj; Ascierto, Pa; Belardelli, F; Camerini, R; Colombo, Mp; Queirolo, P; Ridolfi..., R; Russo, V; Fonsatti, E; Parmiani, G; Calabro', L; Nibit, Collaborators | |
| Ipilimumab experience in heavily pre-treated patients with melanoma in an expanded access program at the University Hospital of Siena (Italy) | 2011 | Di Giacomo, Am; Danielli, R; Calabro', L; Bertocci, E; Nannicini, C; Giannarelli, D; Balestrazzi,... A; Vigni, F; Riversi, V; Miracco, ; Biagioli, M; Altomonte, M; Maio, M | |
| Expression and regulation of the B7-H3 receptor in human mesothelial and mesothelioma cells: a novel target for immunotherapeutic applications | 2011 | Calabro', L; Sigalotti, L; Fonsatti, E; Bertocci, E; Di Giacomo, Am; Danielli, R; Cutaia, O; Coli...zzi, F; Covre, A; Mutti, L; Natali, Pg; Maio, M. | file con accesso da definire |
| Eighth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, October 7-9, 2010 | 2011 | Maio, M; Nicolay, Hj; Ascierto, Pa; Belardelli, F; Camerini, R; Colombo, Mp; Queirolo, P; Ridolfi..., R; Russo, V; Fonsatti, E; Nibit, ; Parmiani, G; Calabro', L | |
| Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy | 2012 | Danielli, R; Ridolfi, R; Chiarion-Sileni, V; Queirolo, P; Testori, A; Plummer, R; Boitano, M; Cal...abro', L; Rossi, Cd; Giacomo, Am; Ferrucci, Pf; Ridolfi, L; Altomonte, M; Miracco, C; Balestrazzi, A; Maio, M. | |
| First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial | 2012 | Gridelli, Cesare; Ciardiello, Fortunato; Gallo, Ciro; Feld, Ronald; Butts, Charles; Gebbia, Vitto...rio; Maione, Paolo; Morgillo, Floriana; Genestreti, Giovenzio; Favaretto, Adolfo; Leighl, Natasha; Wierzbicki, Rafal; Cinieri, Saverio; Alam, Yasmin; Siena, Salvatore; Tortora, Giampaolo; Felletti, Raffaella; Riccardi, Ferdinando; Mancuso, Gianfranco; Rossi, Antonio; Cantile, Flavia; Tsao, Ming-Sound; Saieg, Mauro; da Cunha Santos, Gilda; Carmela Piccirillo, Maria; Di Maio, Massimo; Morabito, Alessandro; Perrone, Francesco; Investigators, Torch; Calabro', Luana | |
| Thymosin α1 in melanoma from the clinical trial setting to the daily practice and beyond | 2012 | Danielli, R; Fonsatti, E; Calabro', L; Giacomo, Am; Maio, M | |
| Quality of Life Analysis of TORCH, a Randomized Trial Testing First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Chemotherapy in Advanced Non-Small-Cell Lung Cancer | 2012 | Di Maio, M; Leighl, Nb; Gallo, C; Feld, R; Ciardiello, F; Butts, C; Maione, P; Gebbia, V; Morgill...o, F; Wierzbicki, R; Favaretto, A; Alam, Y; Cinieri, S; Siena, S; Bianco, R; Riccardi, F; Spatafora, M; Ravaioli, A; Felletti, R; Fregoni, V; Genestreti, G; Rossi, A; Fregoni, V; Genestreti, G; Rossi, A; Mancuso, G; Fasano, M; Morabito, A; Tsao, Ms; Signoriello, S; Perrone, F; Gridelli, C; Torch, Investigators; Calabro', L | |
| Tenth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), SIENA, Italy, November 5-7, 2012 | 2013 | Calabro', Luana | file con accesso da definire |
| Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme | 2013 | Altomonte, M; Di Giacomo, A; Queirolo, P; Ascierto, P; Spagnolo, F; Bajetta, E; Calabro', L; Dani...elli, R; de Rosa, F; Maur, M; Chiarion-Sileni, V; Ferrucci, P; Giannarelli, D; Testori, A; Ridolfi, R; Maio, M. | |
| Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme | 2013 | Di Giacomo, Am; Calabro', L; Danielli, R; Fonsatti, E; Bertocci, E; Pesce, I; Fazio, C; Cutaia, O...; Giannarelli, D; Miracco, C; Biagioli, M; Altomonte, M; Maio, M | |
| Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012 | 2013 | Ascierto, Pa; Grimaldi, Am; Acquavella, N; Borgognoni, L; Calabro', L; Cascinelli, N; Cesano, A; ...Del Vecchio, M; Eggermont, Am; Faries, M; Ferrone, S; Fox, Ba; Gajewski, Tf; Galon, J; Gnjatic, S; Gogas, H; Kashani-Sabet, M; Kaufman, Hl; Larkin, J; Lo, Rs; Mantovani, A; Margolin, K; Melief, C; Mcarthur, G; Palmieri, G; Puzanov, I; Ribas, A; Seliger, B; Sosman, J; Suenaert, P; Tarhini, Aa; Trinchieri, G; Vidal-Vanaclocha, F; Wang, E; Ciliberto, G; Mozzillo, N; Marincola, Fm; Thurin, M. | |
| Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial | 2013 | Calabro', Luana; Aldo, Morra; Ester, Fonsatti; Ornella, Cutaia; Giovanni, Amato; Diana, Giannarel...li; Anna Maria Di Giacomo, ; Riccardo, Danielli; Maresa, Altomonte; Luciano, Mutti; Michele, Maio |
Legenda icone
- file ad accesso aperto
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile